Literature DB >> 17552107

Detection of G12 human rotaviruses in Nepal.

Sher Bahadur Pun1, Toyoko Nakagomi, Jeevan Bahadur Sherchand, Basu Dev Pandey, Luis E Cuevas, Nigel A Cunliffe, C A Hart, Osamu Nakagomi.   

Abstract

Of 731 stool specimens collected from children with diarrhea in Kathmandu, Nepal, from August 2004 through July 2005, 170 (23.3%) tested positive for rotavirus. Reverse transcription-PCR, including a revised G12-specific primer set, identified 56 (32.9%) as G2P[4] and 39 (23.0%) as G12 with P[6], P[8], or P[4].

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17552107      PMCID: PMC2725908          DOI: 10.3201/eid1303.061367

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Globally, ≈700,000 children each year die of rotavirus diarrheal disease, and most such deaths occur in developing countries (,). To reduce this substantial burden of rotavirus diarrhea, 2 live, attenuated oral vaccines have been licensed in >60 countries and are being introduced into the areas where they are most needed (). Nepal is a small, poor, landlocked, subtropical country in Asia where the severe diarrhea is common. During 2003–2004, before Nepal was formally integrated into the Asian Rotavirus Surveillance Network (), a surveillance study was initiated, which showed the emergence of G12 strains against a background of predominant G1P[8] strains (). Since the prevalence of G12 strains was unusually high (20%), and such strains may not be adequately covered by existing vaccines, there was an urgent need to continue surveillance and characterization of rotavirus strains by developing a G12-specific primer pair and to continue to monitor the prevalence of G12 strains in this population.

The Study

Stool specimens were collected from children with acute diarrhea attending the rehydration clinic at Kanti Children’s Hospital, Kathmandu, Nepal, from August 2004 through July 2005. Rotavirus diarrhea was identified by a commercially available ELISA (Rotaclone, Meridian Bioscience, Inc., Cincinnati, OH, USA). From the rotavirus-positive specimens, genomic RNA was extracted by using a QIAamp Viral RNA Mini kit (QIAGEN Sciences, Germantown, MD, USA), and the purified RNA preparations were used to determine G and P types by reverse transcription–PCR (RT-PCR) as described by Uchida et al () and by Gouvea et al. (). For the detection of G12 strains, a new primer pair was designed based on the nucleotide sequence of the VP7 gene of strain Arg720 (). The forward primer, G12F, was 19 mer, corresponding to nucleotide positions 169–187 (5′-GTT GTT GTC ATG CTG CCA T-3′), and the reverse primer, G12R, was 20 mer whose sequence was complementary to nucleotide positions 471–490 (5′-A GTA CAG TAC CAA ATT TCA T-3′). A G12 strain in the stool specimen was identified by the presence of a 322-bp band after electroporesis on agarose gel after PCR typing was done on the first-round RT-PCR product under the same thermal cycling conditions, including an annealing temperature of 42°C. Sequencing was performed on the VP7 gene amplification products with primers Beg9 and End9 (Genomic Research Center, Shimadzu Corporation, Kyoto, Japan). Of 731 stool specimens tested by Rotaclone, 170 (23.3%) were positive for rotavirus antigen. When the distribution of rotavirus-positive cases was examined, 64% occurred in infants ages 3–23 months, whereas only 2.9% occurred in infants <3 months of age. Although samples were not collected in March and April 2005, because of political instability, rotavirus likely circulated among the children in Kathmandu throughout the year. However, a seasonal variation was found in the occurrence of rotavirus diarrhea with a clear peak in January; the rotavirus detection rates varied monthly from 7.3% to 58.6%. Of 170 rotavirus-positive specimens that underwent molecular genotyping, 4 G and 3 P genotypes were found; G2 and G12 together accounted for 62% and P[4] and P[6] together accounted for 74% of their respective genotypes (Table). A total of 10 different G and P genotype combinations were detected, which together accounted for 76% of rotavirus-positive specimens. Ten (6%) mixed infections, as defined by the specimens containing more than 1 G or P genotype, were found, and 31 (18%) specimens remained untypeable. The most common combinations were G2P[4] (33%) and G12P[6] (17%). No G4 strains were detected, nor were any P[6],G12) and rare P3[9] strains related to bovine rotaviruses.. Virology. 2002 ">9] strains found (which are often associated with G3 or G12 VP7 specificity). Since neither G3 nor G9 strains occurred in the preceding season in Kathmandu (), their sudden appearance in Nepal needs continued attention.
Table

Relative frequencies of various combinations of G and P types of human rotaviruses, Kathmandu, Nepal, August 2004 through July 2005

Human rotavirus typesNo. isolates (%)
Total, n (%)
P[4]P[6]P[8]P[9]PmixPNT
G105 (2.9)9 (5.3)02 (1.2)2 (1.2)18 (10.6)
G256 (32.9)5 (2.9)1 (0.6)01 (0.6)4 (2.3)67 (39.4)
G3010 (5.9)000010 (5.9)
G40000000
G80000000
G95 (2.9)00001 (0.6)6 (3.5)
G122 (1.2)29 (17.1)7 (4.1)001 (0.6)39 (23)
Gmix1 (0.6)6 (3.5)00007 (4.1)
GNT6 (3.5)1 (0.6)00016 (9.4)23 (13.5)
Total70 (41.2)56 (33)17 (10)03 (1.7)24 (14.1)170 (100)
The G12 primer pair developed in this study successfully amplified 2 established G12 strains, L26 () and Se585 (), and did not amplify any known G1–G11 and G13–14 strains (Figure 1). Of 39 stool specimens that were found to contain G12 rotavirus by the typing reaction with our G12 primer pair, we selected 12 specimens from those samples that produced the full-length VP7 amplification product for nucleotide sequencing. Each of these VP7 sequences was identified as G12 because the predicted amino-acid sequence was 97%–100% identical with that of prototype G12 strain Se585 in any of antigenic regions A, B, and C (). GenBank accession nos. for G12 VP7 genes were AB275291 (05N054), AB275292 (05K021), AB275293 (05N128), AB275294 (04N605), AB275295 (05N140), AB275296 (05N040), AB275297 (05N065), AB275298 (05K101), AB275299 (05N138), AB275300 (05K046), AB275301 (05K066), and AB275302 (05N145).
Figure 1

Detection after electrophoresis on a 2% agarose gel of the PCR amplification product with a primer pair G12F and G12R. The prototype rotavirus strain for each G serotype was as follows; G1, Wa; G2, KUN; G3, MO; G4, ST3; G5 OSU; G6, NCDV; G7, PO-13; G8, MW33; G9, 95H115; G10, B223; G11, YM; G12, L26; G13, L338; and G14, FI23. The first and last lanes show molecular mass markers in basepairs.

Detection after electrophoresis on a 2% agarose gel of the PCR amplification product with a primer pair G12F and G12R. The prototype rotavirus strain for each G serotype was as follows; G1, Wa; G2, KUN; G3, MO; G4, ST3; G5 OSU; G6, NCDV; G7, PO-13; G8, MW33; G9, 95H115; G10, B223; G11, YM; G12, L26; G13, L338; and G14, FI23. The first and last lanes show molecular mass markers in basepairs.

Conclusions

G12 strains, including those in the first human cases of infection in the Philippines in 1990 (), had only been detected in sporadic cases, yet from geographically diverse locations, including the United States (), Japan (), Brazil (), South Korea (), and Thailand (). However, recent investigations found that that 17% of rotaviruses collected from children with acute diarrhea during 2003–2005 in eastern India and 7.9% of those collected during 1999–2002 in Argentina were of serotype G12 (,). These findings were followed by our previous study, which showed that 20% of rotaviruses collected during 2003–2004 in Nepal were serotype G12 and were equally distributed between children <15 years of age and adults (). The present study (2004–2005) confirms and extends these observations. Twenty-three percent of rotaviruses from the same region in the period immediately following the 2003–2004 study were serotype G12, and most (76%) were combined with P[6] and others with either P[8] or P[4], even though the dominant strains changed from G1P[8] during 2003–2004 (71%) to G2P[4] during 2004–2005 (33%). The detection of G1P[8] decreased to a minimum of 5.3% of all rotavirus-positive strains. The increasing trend of G12 strains in Nepal appears stable and may reflect the overall trend in the Ganges region at large, which justifies further surveillance in Nepal. G12 strains have similarly been detected in multiple seasons elsewhere. In Brazil, G12 strains continued to appear during 1999–2002 (). The emergence and increase in G12P[6] strains may become a challenge to the current rotavirus vaccination strategy, the efficacy of which may depend on the shared G and P serotype specificity of the vaccine strains and wild-type rotavirus strains circulating among children. In this context, the detection of a G12 porcine rotavirus strain with a porcine genetic background in Kolkata, India (), may indicate reservoirs of an unusual yet emerging G genotype in animals. The increase in G12 strains also requires the development of a rapid detection method by PCR using specific primers that specifically target G12 strains. Although 2 earlier papers have described similar primers, neither amplification conditions nor the validation of their specificity for G12 strains have been described. Since we have encountered cross-reactions with rotaviruses carrying other genotypes, i.e, G10, in particular (data not shown), primers were designed and amplification conditions were optimized so that no cross-reactions occurred with prototype rotavirus strains carrying genotypes G1–11 and G13–14. This primer pair should become a valuable asset for the identification of G12 strains found among the nontypeable specimens in many epidemiologic studies since the primer binding sites are well conserved among G12 strains from diverse locations (Figure 2).
Figure 2

Comparison of the primer binding regions of the VP7 genes of G12 rotavirus strains detected in various geographic locations. Primers were designed based on the Arg720 sequence. The sequence of the forward primer is as shown in the figure; the sequence of the reverse primer is complementary to that shown in the figure.

Comparison of the primer binding regions of the VP7 genes of G12 rotavirus strains detected in various geographic locations. Primers were designed based on the Arg720 sequence. The sequence of the forward primer is as shown in the figure; the sequence of the reverse primer is complementary to that shown in the figure.
  16 in total

1.  Characterization of human rotavirus strains with G12 and P[9] detected in Japan.

Authors:  Kuniko Shinozaki; Mineyuki Okada; Shigeo Nagashima; Ikuo Kaiho; Koki Taniguchi
Journal:  J Med Virol       Date:  2004-08       Impact factor: 2.327

Review 2.  A critical time for rotavirus vaccines: a review.

Authors:  Nigel A Cunliffe; Osamu Nakagomi
Journal:  Expert Rev Vaccines       Date:  2005-08       Impact factor: 5.217

3.  Molecular epidemiology of group A rotavirus diarrhea among children in Buenos Aires, Argentina, from 1999 to 2003 and emergence of the infrequent genotype G12.

Authors:  A A Castello; M H Argüelles; R P Rota; A Olthoff; B Jiang; R I Glass; J R Gentsch; G Glikmann
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

4.  Molecular epidemiology of rotavirus diarrhea among children and adults in Nepal: detection of G12 strains with P[6] or P[8] and a G11P[25] strain.

Authors:  Ryuichi Uchida; Basu Dev Pandey; Jeevan Bahadur Sherchand; Kamurddin Ahmed; Michiyo Yokoo; Toyoko Nakagomi; Luis E Cuevas; Nigel A Cunliffe; C A Hart; Osamu Nakagomi
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

5.  Molecular characterization of a porcine Group A rotavirus strain with G12 genotype specificity.

Authors:  S Ghosh; V Varghese; S Samajdar; S K Bhattacharya; N Kobayashi; T N Naik
Journal:  Arch Virol       Date:  2006-02-26       Impact factor: 2.574

6.  Detection of a human rotavirus with G12 and P[9] specificity in Thailand.

Authors:  Y Pongsuwanna; R Guntapong; M Chiwakul; R Tacharoenmuang; N Onvimala; M Wakuda; N Kobayashi; K Taniguchi
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

7.  Changing pattern of human group A rotaviruses: emergence of G12 as an important pathogen among children in eastern India.

Authors:  S Samajdar; V Varghese; P Barman; S Ghosh; U Mitra; P Dutta; S K Bhattacharya; M V Narasimham; P Panda; T Krishnan; N Kobayashi; T N Naik
Journal:  J Clin Virol       Date:  2006-05-06       Impact factor: 3.168

Review 8.  Rotavirus vaccines: current prospects and future challenges.

Authors:  Roger I Glass; Umesh D Parashar; Joseph S Bresee; Reina Turcios; Thea K Fischer; Marc-Alain Widdowson; Baoming Jiang; Jon R Gentsch
Journal:  Lancet       Date:  2006-07-22       Impact factor: 79.321

9.  Rotavirus diarrhea in children and adults in a southern city of Brazil in 2003: distribution of G/P types and finding of a rare G12 strain.

Authors:  Eduardo Pietruchinski; Fabrício Benati; Flávio Lauretti; Jonas Kisielius; Marli Ueda; Eduardo M Volotão; Caroline C Soares; Yasutaka Hoshino; Rosa Elisa C Linhares; Carlos Nozawa; Norma Santos
Journal:  J Med Virol       Date:  2006-09       Impact factor: 2.327

10.  Rotavirus and severe childhood diarrhea.

Authors:  Umesh D Parashar; Christopher J Gibson; Joseph S Bresee; Roger I Glass
Journal:  Emerg Infect Dis       Date:  2006-02       Impact factor: 6.883

View more
  15 in total

1.  First assessment of all-cause acute diarrhoea and rotavirus-confirmed cases following massive vaccination in Argentina.

Authors:  J I Degiuseppe; J A Stupka
Journal:  Epidemiol Infect       Date:  2018-07-13       Impact factor: 2.451

2.  Molecular characterization of VP7 gene of human rotaviruses from Bangladesh.

Authors:  Kamruddin Ahmed; Selim Ahmed; Marcelo Takahiro Mitui; Aminur Rahman; Luthful Kabir; Abdul Hannan; Akira Nishizono; Osamu Nakagomi
Journal:  Virus Genes       Date:  2010-03-10       Impact factor: 2.332

3.  Unexpected substitution of dominant rotavirus G genotypes in French hospitalized children over five consecutive seasons.

Authors:  A de Rougemont; J Kaplon; P Lebon; F Huet; F Denis; S Alain; L Fourcade; J Grosjean; M-J El-Hajje; D Gendrel; P Pothier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-10-15       Impact factor: 3.267

4.  Emergence of G12 rotavirus strains in Delhi, India, in 2000 to 2007.

Authors:  S Sharma; P Ray; J R Gentsch; R I Glass; V Kalra; M K Bhan
Journal:  J Clin Microbiol       Date:  2008-02-13       Impact factor: 5.948

5.  Molecular epidemiology of rotavirus diarrhea among children in Saudi Arabia: first detection of G9 and G12 strains.

Authors:  Ali M Kheyami; Toyoko Nakagomi; Osamu Nakagomi; Winifred Dove; C Anthony Hart; Nigel A Cunliffe
Journal:  J Clin Microbiol       Date:  2008-01-30       Impact factor: 5.948

6.  Rotavirus infection: a perspective on epidemiology, genomic diversity and vaccine strategies.

Authors:  Anupam Mukherjee; Mamta Chawla-Sarkar
Journal:  Indian J Virol       Date:  2011-06-14

7.  Whole Genomic Analysis of Human G12P[6] and G12P[8] Rotavirus Strains that Have Emerged in Myanmar.

Authors:  Tomihiko Ide; Satoshi Komoto; Kyoko Higo-Moriguchi; Khaing Win Htun; Yi Yi Myint; Theingi Win Myat; Kyaw Zin Thant; Hlaing Myat Thu; Mo Mo Win; Htun Naing Oo; Than Htut; Mitsutaka Wakuda; Francis Ekow Dennis; Kei Haga; Yoshiki Fujii; Kazuhiko Katayama; Shofiqur Rahman; Sa Van Nguyen; Kouji Umeda; Keiji Oguma; Takao Tsuji; Koki Taniguchi
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

8.  Serotype g12 rotaviruses, Lilongwe, Malawi.

Authors:  Nigel A Cunliffe; Bagrey M Ngwira; Winifred Dove; Osamu Nakagomi; Toyoko Nakagomi; Arantza Perez; C Anthony Hart; Peter N Kazembe; Charles C V Mwansambo
Journal:  Emerg Infect Dis       Date:  2009-01       Impact factor: 6.883

9.  Continued Circulation of G12P[6] Rotaviruses Over 28 Months in Nepal: Successive Replacement of Predominant Strains.

Authors:  Punita Gauchan; Toyoko Nakagomi; Jeevan B Sherchand; Michiyo Yokoo; Basu Dev Pandey; Nigel A Cunliffe; Osamu Nakagomi
Journal:  Trop Med Health       Date:  2013-02-06

10.  Identification of a rotavirus G12 strain, Indonesia.

Authors:  Wahyu N Wulan; Erlin Listiyaningsih; Kiki M K Samsi; Magdarina D Agtini; Matthew R Kasper; Shannon D Putnam
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.